ALLIANCE FOR SAFE BIOLOGIC MEDICINESPub 78
Pub 78
Programs
Biosimilar Coalition Building
BUILD COALITION AND COLLABORATE WITH GROUPS THAT HAVE SIMILAR INTERESTS ON BIOSIMILAR, INCLUDING PATIENTS AND PATIENT GROUPS, PHYSICIANS AND OTHER HEALTH PROFESSIONALS, ACADEMIA, COMPANIES AND TRADE ASSOCIATIONS.GeographiesNot indicatedDatesJan 1, 2023 – Dec 31, 2023Source990No causes providedNo populations provided–$163.8KMedia Engagement and Outreach
SERVING AS A NEWS AUTHORITY FOR THE MEDIA INCLUDING: DEVELOPING AND DISTRIBUTED PRESS MATERIALS, SUCH AS PRESS RELEASES, OP-EDS LETTERS TO THE EDITOR FROM OUR PARTNERSHIP; SERVING OR CONNECTING MEDIA TO EXPERT COALITION MEMBERS TO COMMENT ON NEWS INVITING MEDIA TO ROUNDTABLE FORUMS AND EVENTS; AND TWEETING ON IMPORTANT NEWS.GeographiesNot indicatedDatesJan 1, 2023 – Dec 31, 2023Source990No causes providedNo populations provided–$163.8KBiosimilar Education and Resources
SERVE AS AN AUTHORITATIVE RESOURCE AND EDUCATION CENTER FOR INFORMATION ON BIOSIMILAR FOR THE PUBLIC, MEDICAL COMMUNITY AND REGULATORY BODIES BY: HOSTING EDUCATION FORUMS, ROUNDTABLES AND GIVING PRESENTATIONS AT NATIONAL CONFERENCES; SPEAKING AT PUBLIC HEARINGS ON CAPITOL HILL, AT THE FDA, WHO AND OTHER GOVERNMENTAL MEETINGS ACROSS THE GLOBE.GeographiesNot indicatedDatesJan 1, 2023 – Dec 31, 2023Source990No causes providedNo populations provided–$163.8K
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)